Characterization of HIV-1 protease mutants: random, directed, selected

Area of Science:

• Biochemistry
• Virology
• Drug Discovery

Background:

• The human immunodeficiency virus type 1 (HIV-1) protease is a critical enzyme in the viral replication cycle.
• It is a primary target for the development of antiretroviral therapies.
• Understanding its structure and function is crucial for combating HIV-1 infection.

Purpose of the Study:

• To highlight the significance of HIV-1 protease as a therapeutic target.
• To discuss current research methodologies employed in studying HIV-1 protease.
• To underscore the importance of structural and mutational analyses in drug development.

Main Methods:

• Recombinant protein expression and purification of HIV-1 protease.
• X-ray crystallography for determining enzyme structures with and without inhibitors.
• Mutational analysis to investigate protease function and inhibitor resistance.

Main Results:

• Numerous crystal structures of HIV-1 protease have been determined, providing detailed insights into its active site.
• Recombinant protease is readily available for extensive biochemical and structural studies.
• The emergence of HIV-1 mutants resistant to protease inhibitors provides valuable information on resistance mechanisms.

Conclusions:

• HIV-1 protease remains a highly attractive target for anti-HIV-1 drug development.
• Structural biology and mutational studies are essential for understanding protease function and guiding therapeutic strategies.
• Continued research, including the study of resistant mutants, is vital for advancing HIV-1 treatment.